Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
850 USD | +1.52% | +3.61% | +45.82% |
Jun. 07 | Jefferies Adjusts Price Target on Eli Lilly to $957 From $925 | MT |
Jun. 07 | US FDA Staff Flags Potential Limited Benefit of Eli Lilly's Alzheimer's Disease Drug | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+45.82% | 765B | |
+40.95% | 632B | |
-6.16% | 354B | |
+19.86% | 331B | |
+9.32% | 299B | |
+18.45% | 248B | |
-0.78% | 219B | |
+11.88% | 216B | |
+5.90% | 164B | |
-0.73% | 162B |
- Stock Market
- Equities
- LLY Stock
- News Eli Lilly and Company
- Transcript : Eli Lilly and Company, Q1 2024 Earnings Call, Apr 30, 2024